Article

Applied Clinical Trials

Advarra Announces Intent to Acquire Forte

Advarra has announced its the intent to acquire Forte and is expecting to close later in this month.

For details, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
© JHVEPhoto - © JHVEPhoto - stock.adobe.com
August 27th 2025

FDA Authorizes New COVID Vaccines with Restrictions on Eligibility

Davy James
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
August 27th 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
Credit: photon_photo | stock.adobe.com. Clinical trial success depends on selecting appropriate clinical sites. Poor site selection can lead to delayed recruitment, compromised data quality, increased costs, and regulatory risks
August 27th 2025

Beyond Prediction: An Evidence-Based Framework for Assessing Site Selection Decisions

Anh Ninh, Linh Nguyen and Daniel Butler
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
August 27th 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer
August 27th 2025

Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer

Don Tracy, Associate Editor
© Shuo - © Shuo - stock.adobe.com
August 27th 2025

Bias Starts Early in Research. So Can AI.

Stavroula Ntoufa
© 2025 MJH Life Sciences

All rights reserved.